Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma is an aggressive and deadly form of cancer that starts in the cells of the pancreas. It is the fourth leading cause of cancer-related deaths in the United States, due to its tendency to spread quickly and its difficulty to detect in the early stages. Symptoms can include abdominal pain, weight loss, yellowing of the skin, and fatigue. Treatment options include chemotherapy, radiation, and surgery. With early detection and treatment, survival rates can be improved and quality of life can be extended for those affected by Pancreatic Adenocarcinoma.

← Journal of Pancreas

Related Articles

5 article(s) found

The Bromine, Calcium, Potassium, Magnesium, Manganese, and Sodium Contents in Adenocarcinoma of Human Prostate Gland

Full-text HTML Download PDF Download XML

In Vitro Assessment of Estrogenic Potential of Biofield Energy Treatment using Human Endometrial Adenocarcinoma Cell Line

Full-text HTML Download PDF Download XML

A Case of Collision Tumor of MALT Lymphoma and Poorly Differentiated Adenocarcinoma Diagnosed Incidentally After Appendectomy for a Clinical Presentation of Acute Appendicitis.

Full-text HTML Download PDF Download XML

Massive Hematemesis as Initial Presentation of Advanced Pancreatic Adenocarcinoma

Full-text HTML Download PDF Download XML

Pancreatic cancer in a Non-Tertiary Center: CEA and Bilirubin More Predictive than CA 19-9 at Initial Presentation

Full-text HTML Download PDF Download XML